1
Berghuis, A.S., Koffijberg, H., van Deurzen, C., Sleijfer, S., Terstappen, L.W., IJzerman, M.
Veröffentlicht in: Value in Health ; volume 21, page S247-S248 ; ISSN 1098-3015;
2018
Veröffentlicht in: Value in Health ; volume 21, page S247-S248 ; ISSN 1098-3015;
2018
2
3
Kip, Michelle M. A., van Oers, Jos A., Shajiei, Arezoo, Beishuizen, Albertus, Berghuis, A. M. Sofie, Girbes, Armand R., de Jong, Evelien, de Lange, Dylan W., Nijsten, Maarten W. N., IJzerman, Maarten J., Koffijberg, Hendrik, Kusters, Ron
Veröffentlicht in: Kip , M M A , van Oers , J A , Shajiei , A , Beishuizen , A , Berghuis , A M S , Girbes , A R , de Jong , E , de Lange , D W , Nijsten , M W N , IJzerman , M J , Koffijberg , H & Kusters , R 2018 , ' Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients : results from a randomised controlled multicentre trial in the Netherlands ' , Critical Care , vol. 22 , 293 . https://doi.org/10.1186/s13054-018-2234-3;
2018
Veröffentlicht in: Kip , M M A , van Oers , J A , Shajiei , A , Beishuizen , A , Berghuis , A M S , Girbes , A R , de Jong , E , de Lange , D W , Nijsten , M W N , IJzerman , M J , Koffijberg , H & Kusters , R 2018 , ' Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients : results from a randomised controlled multicentre trial in the Netherlands ' , Critical Care , vol. 22 , 293 . https://doi.org/10.1186/s13054-018-2234-3;
2018
4
Kip, Michelle M. A., van Oers, Jos A., Shajiei, Arezoo, Beishuizen, Albertus, Berghuis, A. M. Sofie, Girbes, Armand R., de Jong, Evelien, de Lange, Dylan W., Nijsten, Maarten W. N., IJzerman, Maarten J., Koffijberg, Hendrik, Kusters, Ron
Veröffentlicht in: Kip , M M A , van Oers , J A , Shajiei , A , Beishuizen , A , Berghuis , A M S , Girbes , A R , de Jong , E , de Lange , D W , Nijsten , M W N , IJzerman , M J , Koffijberg , H & Kusters , R 2018 , ' Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands ' , Critical Care , vol. 22 , no. 1 , pp. 293 . https://doi.org/10.1186/s13054-018-2234-3;
2018
Veröffentlicht in: Kip , M M A , van Oers , J A , Shajiei , A , Beishuizen , A , Berghuis , A M S , Girbes , A R , de Jong , E , de Lange , D W , Nijsten , M W N , IJzerman , M J , Koffijberg , H & Kusters , R 2018 , ' Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands ' , Critical Care , vol. 22 , no. 1 , pp. 293 . https://doi.org/10.1186/s13054-018-2234-3;
2018